0% found this document useful (0 votes)
20 views33 pages

DM in Pregnancy

The document discusses the increasing prevalence of diabetes during pregnancy, including type 1, type 2, and gestational diabetes, and their associated risks for adverse outcomes. It outlines the management strategies for women with pre-existing diabetes and gestational diabetes, emphasizing the importance of glycemic control and nutritional therapy. Additionally, it highlights the need for postpartum care and the potential benefits of breastfeeding for both mother and child.

Uploaded by

Neim Bedewi
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
20 views33 pages

DM in Pregnancy

The document discusses the increasing prevalence of diabetes during pregnancy, including type 1, type 2, and gestational diabetes, and their associated risks for adverse outcomes. It outlines the management strategies for women with pre-existing diabetes and gestational diabetes, emphasizing the importance of glycemic control and nutritional therapy. Additionally, it highlights the need for postpartum care and the potential benefits of breastfeeding for both mother and child.

Uploaded by

Neim Bedewi
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd

Diabetes

During
Pregnancy
By: Neim Bedewi
1
Introduction
 An increasing number of pregnancies are
complicated by diabetes, whether type 1
diabetes (T1DM), type 2 diabetes (T2DM)
or gestational diabetes (GDM)
 All of which are associated with an
increased risk of adverse outcomes
2
Introduction….
Pre-existing DM in pregnancy (T1DM
& T2DM)
 DM diagnosed before pregnancy
 The prevalence of pre-existing DM has
increased due to the increase in T2DM
 Higher rates of complications Vs. general
popn …. Perinatal mortality, congenital
malformations (4X), hypertension,
3

preterm delivery, large-for-gestational-


Introduction….
Gestational Diabetes Mellitus
 DM diagnosed in the 2nd or 3rd trimester of
pregnancy that was not clearly overt diabetes
prior to gestation
 Obesity combined with advancing maternal
age, has driven an increase in the
prevalence of GDM
 Risk of adverse maternal, fetal, and
4

neonatal outcomes…. macrosomia (birth


Risk factors for
GDM
 BMI in the obese range (above 30 kg/m2)
 Previous macrosomic baby weighing 4.5
kg
 Previous gestational diabetes
 Family history of diabetes (first-degree
relative with diabetes)
 Ethnicity: South Asian, Black Caribbean,
5

Middle Eastern
DKA in Pregnancy
 A serious condition associated with greatly
increased perinatal morbidity & mortality
 Often at lower blood glucose levels
(even below 180 mg/dl or 10 mmol/l),
DKA can happen insidiously & with
higher GFR and lower renal threshold
for glycosuria in pregnancy 6
Insulin Physiology
 Early pregnancy…. enhanced insulin
sensitivity & lower glucose levels
 Women with T1DM will have lower
insulin requirements & increased risk
for hypoglycemia
 Around 16 wks., insulin resistance begins
to increase, & total daily insulin doses
7
increase linearly 5% per wk. through week
Physiology….
 A rapid reduction in insulin requirements
can indicate the development of placental
insufficiency
 In women with normal pancreatic function,
insulin production is sufficient to meet the
challenge of this physiological insulin
8
resistance
Diagnosis

9
Criteria for the diagnosis of
diabetes

10
screening
One-step strategy
 Perform a 75-g OGTT, with PG measurement when
pt. is fasting & at 1 & 2 h, at 24–28 wks. of
gestation in women not previously diagnosed with
DM.
 OGTT.. in the morning after an overnight fast of at
least 8 h.
 GDM if any of the following PG values are met or
11
exceeded:

Cont.…
Two-step strategy
 Step 1
 Perform a 50-g GLT (non-fasting), with
PG measurement at 1 h, at 24–28 wks.
of gestation in women not previously
diagnosed with DM
 If the plasma glucose level measured
1 h after the load is 130, 135, or 140
12
Cont.…
Two-step strategy….
 Step 2: The 100-g OGTT should be performed
when the pt. is fasting
 GDM, if at least 2 of the following 4 PG levels
(measured fasting & at 1,2, & 3h during OGTT)
are met or exceeded:
 Fasting: 95 mg/dL (5.3 mmol/L)
 1 h: 180 mg/dL (10.0 mmol/L)
13
 2 h: 155 mg/dL (8.6 mmol/L)
Care
 Women with preexisting DM who are
planning a pregnancy should ideally be
managed beginning in preconception in a
multidisciplinary clinic
 In addition to achieving glycemic targets
 Preconception care focus on nutrition,
14
diabetes education, & screening for
Cont.…
 Counseling on the risk of development
and/or progression of diabetic retinopathy
 Dilated eye examinations in the 1st
trimester, and then every trimester &
for 1 year postpartum as indicated by
the degree of retinopathy 15
Glycemic Targets
 FPG 70-95 mg/dL
 One-hour postprandial glucose 110-140
mg/dL
 Two-hour postprandial glucose 100-
120mg/dL
 A1C target in pregnancy is < 6% (42
16

mmol/mol)
Manageme
nt
17
Management
 Medical nutrition therapy
 Physical activity, and
 Weight management (depend on pre-
gestational weight)

18
Therapy
 For all pregnant women recommends a
minimum of
 175 g of carbohydrate,
 71 g protein, and
 28 g of fiber
 While limiting saturated fats and avoiding
trans fats, but unsaturated fats are
19

recommended
GDM Management
 Insulin is the 1st-line agent recommended
for treatment of GDM
 Metformin and glyburide, are not
recommended as 1st-line treatment for
GDM because they are known to cross the
placenta
20
 Studies shown that both drugs failed to
Therapy
 Glyburide…. higher rate of neonatal
hypoglycemia & macrosomia Vs. insulin or
metformin
 Metformin Vs. Insulin
 The earlier associated with a lower risk
of neonatal hypoglycemia & less
maternal wt. gain
21
 But, growth restriction or acidosis in the
GDM….
 Both multiple daily insulin injections and
continuous subcutaneous insulin infusion
are reasonable delivery strategies
 Neither of them has been shown to
be superior to the other during
pregnancy
22
Management
 Insulin should be used for management of
T1DM during pregnancy
 Also, it is the preferred one for T2DM
management in pregnancy
 Either multiple daily injections or insulin
pump technology can be used in
23
pregnancy complicated by type 1 diabetes
Type 1 DM
 Women with type 1 diabetes have an
increased risk of hypoglycemia in the 1st
trimester
 Pregnancy is a ketogenic state, and
women with T1DM, & to a lesser extent
those with T2DM, are at risk for DKA at
24
lower BG levels
Type 1 DM
 DKA carries a high risk of stillbirth
 Women in DKA who are unable to eat
often require 10% dextrose with an
insulin drip
 To adequately meet carbohydrate
demands of the placenta & fetus in
25

the 3rd trimester in order to resolve


Type 2 DM
 Glycemic control is often easier to achieve
in women with T2DM than in those with
T1DM
 But can require much higher doses of
insulin
 The risk for associated hypertension and
26

other comorbidities may be as high or


Use
 Low-dose ASA, 100–150 mg/day starting
at 12 to 16 wks. of gestation to lower the
risk of preeclampsia
 Cost benefit analysis conclude that
 Reduce morbidity, save lives, & lower
health care costs
 Needed to assess the long-term effects of
27

prenatal ASA exposure on offspring


Postpartum Care
 Insulin resistance decreases dramatically
immediately postpartum
 Insulin requirements need to be
evaluated and adjusted
 A contraceptive plan should be discussed
and implemented with all women with
diabetes of reproductive potential 28
Lactation
 Breastfeeding may also confer longer-
term metabolic benefits to both
mother & offspring
 However, lactation can increase the
risk of overnight hypoglycemia
29

 Insulin dosing may need to be


References
American Diabetes Association. Classification and diagnosis of
diabetes: Standards of Medical Care in Diabetes_2021.
Diabetes Care 2021;44(Suppl. 1):S152S33

American Diabetes Association. Management of diabetes in


pregnancy: Standards of Medical Care in Diabetes_2021.
Diabetes Care 2021;44(Suppl. 1):S200–S210

Farrar D, Tuffnell DJ, West J, West HM. Continuous


subcutaneous insulin infusion versus multiple daily
30

injections of insulin for pregnant women with diabetes.


Langer O, Conway DL, Berkus MD, Xenakis EM-J, Gonzales
O. A comparison of glyburide and insulin in women with
gestational diabetes mellitus. N Engl J Med
2000;343:1134–1138

Padmanabhan S, Lee VW, Mclean M. The association of


falling insulin requirements with maternal biomarkers
and placental dysfunction: a prospective study of women
with preexisting diabetes in pregnancy. Diabetes Care
2017; 40:1323–1330
31

Rowan JA, Hague WM, Gao W, Battin MR, Moore MP; MiG
Werner EF, Hauspurg AK, Rouse DJ. A cost benefit analysis
of low-dose aspirin prophylaxis for the prevention of
preeclampsia in the United States. Obstet Gynecol
2015;126:1242–1250

32
THANK
U….
33

You might also like